The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Parent entities and officers
Active
3
- 1
Smith, Owen Philip
Investment Director born in July 1986Individual (3 offsprings)Officer
2019-11-08 ~ dissolvedOF - Director → CIF 0 - 2
Sinclair, Andrew, Dr
Partner At Venture Capital Llp born in December 1971Individual (1 offspring)Officer 2021-11-04 ~ dissolvedOF - Director → CIF 0 - 3
Richon, Victoria Marie
Director born in March 1959Individual (1 offspring)Officer 2022-08-03 ~ dissolvedOF - Director → CIF 0
Ceased
6
- 1
Lazarus, Alon, Dr
Biotech Investment Manager born in February 1975IndividualOfficer 2019-11-08 ~ 2023-10-11OF - Director → CIF 0 - 2
Walsh, Colin, Dr
Partner born in May 1985Individual (1 offspring)Officer 2021-11-04 ~ 2023-09-22OF - Director → CIF 0 - 3
Sheppard, David William, Dr
Director born in March 1974Individual (3 offsprings)Officer 2019-07-17 ~ 2022-07-09OF - Director → CIF 0Dr David William Sheppard
Born in March 1974Individual (3 offsprings)Person with significant control 2019-07-17 ~ 2019-11-08PE - Ownership of shares – 75% or more → CIF 0PE - Ownership of voting rights - 75% or more → CIF 0PE - Right to appoint or remove directors → CIF 0 - 4
Gaster, Richard, Dr
Venture Capital born in June 1984IndividualOfficer 2021-11-04 ~ 2023-10-10OF - Director → CIF 0 - 5
6 Hachoshlim St., 4672406, Building C, 6th Floor, Herzliya, IsraelCorporatePerson with significant control2019-10-25 ~ 2021-11-04PE - Ownership of shares – More than 25% but not more than 50% → CIF 0PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0 - 64BIO VENTURES II L.P.78, Pall Mall, London, EnglandActive Corporate (1 offspring)Person with significant control2019-10-25 ~ 2021-11-04PE - Ownership of shares – More than 25% but not more than 50% → CIF 0PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
Company in focus
ENTACT BIO LIMITED
Previous names
LOCKI THERAPEUTICS LIMITED - 2022-07-08
PROTECT THERAPEUTICS LIMITED - 2019-12-05
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Turnover/Revenue
0 GBP2019-07-17 ~ 2020-07-31
Cost of Sales
0 GBP2019-07-17 ~ 2020-07-31
Gross Profit/Loss
0 GBP2019-07-17 ~ 2020-07-31
Distribution Costs
0 GBP2019-07-17 ~ 2020-07-31
Administrative Expenses
-556,390 GBP2019-07-17 ~ 2020-07-31
Operating Profit/Loss
-556,390 GBP2019-07-17 ~ 2020-07-31
Profit/Loss on Ordinary Activities Before Tax
-556,390 GBP2019-07-17 ~ 2020-07-31
Tax/Tax Credit on Profit or Loss on Ordinary Activities
116,478 GBP2019-07-17 ~ 2020-07-31
Called-up share capital not yet paid and not classified as a current asset
0 GBP2020-07-31
Intangible Assets
0 GBP2020-07-31
Property, Plant & Equipment
2,113 GBP2020-07-31
Fixed Assets - Investments
0 GBP2020-07-31
Fixed Assets
2,113 GBP2020-07-31
Total Inventories
0 GBP2020-07-31
Debtors
116,478 GBP2020-07-31
Cash at bank and in hand
580,378 GBP2020-07-31
Current assets - Investments
0 GBP2020-07-31
Current Assets
696,856 GBP2020-07-31
Net Current Assets/Liabilities
558,706 GBP2020-07-31
Total Assets Less Current Liabilities
560,819 GBP2020-07-31
Creditors
Amounts falling due after one year
0 GBP2020-07-31
Net Assets/Liabilities
560,819 GBP2020-07-31
Equity
Called up share capital
731 GBP2020-07-31
Share premium
0 GBP2020-07-31
Retained earnings (accumulated losses)
-439,912 GBP2020-07-31
Equity
560,819 GBP2020-07-31
Average Number of Employees
22019-07-17 ~ 2020-07-31
Property, Plant & Equipment - Gross Cost
Office equipment
2,525 GBP2020-07-31
Property, Plant & Equipment - Gross Cost
2,525 GBP2020-07-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Office equipment
412 GBP2019-07-17 ~ 2020-07-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
412 GBP2019-07-17 ~ 2020-07-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Office equipment
412 GBP2020-07-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
412 GBP2020-07-31
Property, Plant & Equipment
Office equipment
2,113 GBP2020-07-31
Other Debtors
116,478 GBP2020-07-31
Trade Creditors/Trade Payables
Amounts falling due within one year
75,620 GBP2020-07-31
Taxation/Social Security Payable
Amounts falling due within one year
15,258 GBP2020-07-31
Accrued Liabilities/Deferred Income
Amounts falling due within one year
47,272 GBP2020-07-31
ENTACT BIO LIMITED
InfoLOCKI THERAPEUTICS LIMITED - 2022-07-08PROTECT THERAPEUTICS LIMITED - 2019-12-05Registered number 121076302 Royal College Street, London NW1 0NHPrivate Limited Company incorporated on 2019-07-17 and dissolved on 2024-12-03 (5 years 4 months). The company status is Dissolved.The last date of confirmation statement was made at 2024-07-16CIF 0
Offspring entities and appointments
Active
0
- Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and
licensed under the Open Government Licence v3.0.